Surmodics (NASDAQ:SRDX – Get Free Report) and Artivion (NYSE:AORT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership. Profitability This table compares Surmodics and Artivion’s net margins, […]
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at.
/PRNewswire/ The endovascular abdominal aortic aneurysm repair devices market size is expected to grow by USD 697.78 million from 2022 to 2027. In addition,.
/PRNewswire/ The Global Soft Tissue Repair Market size is projected to grow by USD 3.42 billion, accelerating at a CAGR of over 4.5% during the forecast.
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present.